Biologic Drug Product CDMO Benchmarking (6th Ed.)

Report Overview

Industry Standard Research (ISR) takes pride in our suite of Quality Benchmarking work and this study is no exception. The Biologic Drug Product CMO Benchmarking (6th edition) has a wealth of information, created with two goals in mind: (1) Help biopharmaceutical companies make more informed CMO selection decisions, and (2) Help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of outsourcing trends and practices. Included with this is a quantitative analysis of CMO service quality across 23 performance attributes specific to outsourced drug product manufacturing. Discover the key attributes that contract manufacturing decision-makers are using to drive CMO selection for biologic drug product manufacturing. Learn how individual CMOs perform along important dimensions through analysis of 449 captured service encounters among 134 respondents.

What you will learn:

Drug Developers:

• Understand which manufacturers best fit your company’s needs and how individual CMOs have performed compared to competition
• Discover which attributes have gained importance over the past 12 months among industry peers
• Compare how CMOs are measuring up to sponsor-peer expectations across more than 20 attributes and hear directly from sponsors how their experience was with each CMO, along with an overall satisfaction rating

Contract Manufacturers:

• Gain knowledge of your strengths and weaknesses and use this information to develop targeted messaging to showcase your perceived and real strengths
• Understand your performance – and compare among competitors – across 23 performance metrics specific to outsourced manufacturing
• Develop insight into drug developer’ outsourcing practices, preferences, and loyalty when it comes to CMO selection for outsourcing biologic drug product manufacturing

Major Topics:

• Outsourcing Philosophies and Practices
• CMO Selection Drivers
• CMO Performance and Loyalty
• The Biologic Drug Product CMO Competitive Landscape
• Company Service Quality Profiles
• Study Data